Skip to main content
OpenTrials
Completed

NCT Number: NCT00396903

Evaluation of a Standard Epidural Catheter During Clinical Practice

During the insertion of epidural catheters several complications can occur, including transient paraesthesia and inadvertent venous cannulation.

Reported incidences for paraesthesia vary widely between about 0.2% and 50% in different articles, depending on the catheter (catheter material, soft-tipped or firm-tipped catheter), the applied technique (lumbar or thoracic epidural anesthesia, depth of catheter insertion), the approach (midline or paramedian) and the included patients (obstetrical or non-obstetrical). Furthermore, the inconsistent definition of "paraesthesia" makes it difficult to compare the results of different studies. Paraesthesia are not supposed to lead to permanent neurological sequelea, but are unpleasant and perturbing sensations for the patient.

For inadvertent venous cannulation during epidural catheter placement, incidences between 1% and 14% have been reported. As for the paraesthesia rate, catheter material, technique, approach and included patients are determinants for the incidence of vessel puncture.

Main objective of this study is to determine the incidence of paraesthesia with this catheter.

Secondary objectives are to record

* the frequency of inadvertent venous cannulation * difficulties involved in insertion and removal of the catheter * data on additional complications * data for the evaluation of handling characteristics

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Maastricht

Maastricht, 6202 AZ, Netherlands

About this study

Study design

This study is a prospective, uncontrolled, open, non-randomised study ("Observational Study") with a CE-certified medical device.

Patients

Information and consent Information of the procedure and oral consent of epidural anaesthesia for the surgery is obtained as usual. Oral consent for data collection has to be obtained. No randomisation or blinding is performed and no non-standard procedures are necessary.

Inclusion criteria

100 patients scheduled for Epidural Anaesthesia will be included in this study. Eligible patients are ASA class I-III, between 18 and 75 years of age and are scheduled for EA, with or without general anaesthesia.

Exclusion criteria

Anamnestic exclusion criteria are all contraindications for epidural anaesthesia (e.g. neurological deficit, skin infection of the puncture site, diseases leading to neurological impairment such as diabetes, coagulation impairment). Non-competent and non-cooperative patients as well as pregnant and breast-feeding women are also to be excluded. Same applies for patients with medicament- and drug abuse or problems in communication or those participating in parallel in another clinical study with experimental drugs or devices.

Randomisation and Blinding No randomization is required. An independent observer who is not performing the epidural will record occurrence, incidence and intensity of paraesthesia.

Definition of the main and the secondary criteria

Main criteria

  • Frequency of paraesthesia during catheter insertion

Secondary criteria

  • Frequency of inadvertent venous cannulation (aspiration of blood)
  • Intensity of paraesthesia (VAS)
  • description: - pain
  • electric shock
  • burning sensation
  • shooting effect
  • motor reactions (right/left)
  • discomfort
  • others
  • Frequency and kind of difficulties during insertion of the catheter (rating of "easiness of insertion": 0 = no resistance, 1 = minor difficulties, 2 = serious difficulties, 3 = impossible)
  • Facultative: Documentation of paraesthesia/difficulties during catheter removal at 48 hours after surgery (or earlier, if appropriate)

Concomitant parameters

  • Patient data (age, height, weight, sex, diagnosis, kind of intervention, ASA class, relevant co-diagnosis, relevant co-medication)
  • Epidural anaesthesia and -analgesia related data
  • Data that relate to the description of the puncture process and method chosen in case of difficulties during puncture, catheter insertion and removal
  • Level of sensory blockade
  • Indwelling time of epidural catheter by recording the time of insertion
  • Dose/kind of anaesthetic used for epidural anaesthesia, type of general anaesthesia if relevant
  • Kind of analgesia done by epidural catheter
  • Adequacy of epidural anaesthesia (yes / no)
  • Further complications/side effects related to epidural anaesthesia/analgesia (i.e. dural puncture, haematoma, etc)
  • Judgement of the anaesthesiologist concerning handling features (0 = no resistance, 1 = minor difficulties, 2 = serious difficulties)
  • Catheter damages

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • scheduled for Epidural Anaesthesia
  • ASA class I-III
  • between 18 and 75

Exclusion criteria

  • contraindications for epidural anaesthesia
  • Non-competent and non-cooperative
  • pregnant and breast-feeding women
  • medicament- and drug abuse or problems in communication
  • participating in parallel in another clinical study with experimental drugs or devices

Treatment and study plan

catheter

Device

Primary outcomes

  1. Frequency of paraesthesia during catheter insertion

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Registry information

Important dates

Study start
2003
Study completion
2005
First posted
Nov 8, 2006
Registry last updated
Apr 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.